Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial

Name: Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial
License: Public Domain

HuidaGene Therapeutics Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

neovascular age-related macular degeneration (namd)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287426
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.